Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- bài báo khoa học (vi)
- article scientifique (publié 2007) (fr)
- наукова стаття, опублікована в січні 2007 (uk)
- im Januar 2007 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu en xineru de 2007 (ast)
- artikull shkencor i botuar më 01 janar 2007 (sq)
- scientific article published on 01 January 2007 (en)
|
publication date
| |
publication date
| |
author name string
| |
author name string
| - Luca Borradori
- Michael Hertl
- Rüdiger Eming
|
rdfs:label
| - Rituximab (anti-CD20 monoclonal antibody)--ultimate or first choice in pemphigus? (en)
- Rituximab (anti-CD20 monoclonal antibody)--ultimate or first choice in pemphigus? (nl)
- Rituximab (anti-CD20 monoclonal antibody)--ultimate or first choice in pemphigus? (sq)
|
skos:prefLabel
| - Rituximab (anti-CD20 monoclonal antibody)--ultimate or first choice in pemphigus? (en)
- Rituximab (anti-CD20 monoclonal antibody)--ultimate or first choice in pemphigus? (nl)
- Rituximab (anti-CD20 monoclonal antibody)--ultimate or first choice in pemphigus? (sq)
|
name
| - Rituximab (anti-CD20 monoclonal antibody)--ultimate or first choice in pemphigus? (en)
- Rituximab (anti-CD20 monoclonal antibody)--ultimate or first choice in pemphigus? (nl)
- Rituximab (anti-CD20 monoclonal antibody)--ultimate or first choice in pemphigus? (sq)
|
title
| |
title
| - Rituximab (anti-CD20 monoclonal antibody)--ultimate or first choice in pemphigus? (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| |
is about
of | |
is cites work
of | |
is cites work
of | |